AGENT FOR TREATMENT OF PATHOLOGICAL OSSEOUS METABOLISM Russian patent published in 2004 - IPC

Abstract RU 2223782 C2

FIELD: medicine, biochemistry. SUBSTANCE: invention relates to agent used for treatment of pathological osseous metabolism. Agent comprises at least one substance taken among the group consisting of osteoclastogenesis-inhibiting factor (OCIF), its homologs and variants and polysaccharide or its derivatives. As polysaccharide or its derivatives heparin, dextran sulfate and related substances can be used. Invention provides the excellent therapeutic effect in such species of pathological osseous metabolism as osteoporosis, hypercalcemia or chronic articulation rheumatism and shows the stable activity. EFFECT: enhanced effectiveness of agent, valuable medicinal properties. 6 cl, 10 dwg

Similar patents RU2223782C2

Title Year Author Number
COMPLEX COMPRISING OSTEOCLASTOGENESIS-INHIBITORY FACTOR (OCIF) AND POLYSACCHARIDE 2002
  • Jamamoto Siniti
  • Okada Dzuniti
  • Kurikhara Atsusi
  • Numazava Taku
  • Kondo Dzuniti
  • Tsuda Eisuke
  • Motizuki Siniti
  • Nisi Khirotaka
  • Mijazaki Khideki
RU2232594C2
PROTEIN BINDING SPECIFICALLY WITH OSTEOCLASTOGENESIS-INHIBITING FACTOR (OCIF) (VARIANTS), DNA ENCODING ITS (VARIANTS), DNA AS PROBE (VARIANTS), METHOD FOR PREPARING PROTEIN (VARIANTS), METHOD FOR SCREENING SUBSTANCE (VARIANTS), ANTIBODY (VARIANTS), METHOD FOR PREPARING POLYCLONAL ANTIBODY, HYBRIDOMA (VARIANTS), METHOD FOR PREPARING MONOCLONAL ANTIBODY, METHOD FOR ASSAY OF OCIF-BINDING PROTEIN, PHARMACEUTICAL COMPOSITION (VARIANTS) AND MEDICINAL AGENT (VARIANTS) 1998
  • Jamaguti Kiodzi
  • Jasuda Khisataka
  • Nakagava Nobuaki
  • Sima Nobujuki
  • Kinosaki Masakhiko
  • Tsuda Eisuke
  • Goto Masaaki
  • Jano Kazuki
  • Tomojasu Akikhiro
  • Kobajasi Fumie
  • Vasida Naokhiro
  • Takakhasi Ken
  • Morinaga Tomonori
  • Khigasio Kandzi
RU2238949C2
METHOD FOR DIAGNOSING THE CASES OF BONE METABOLISM DISORDER DISEASES 1998
  • Jano Kazuki
  • Kobajasi Fumie
  • Goto Masaaki
  • Vasida Naokhiro
  • Tsuda Ehjsuke
  • Khigasio Kandzi
  • Jamada Josidzi
RU2203497C2
METHODS FOR TREATMENT OF COAGULOPATHIES WITH APPLICATION OF SULPHATED POLYSACCHARIDES 2005
  • Dzhonson Kirk V.
RU2347574C2
PROTEIN ABLE TO INHIBIT OSTEOCLASTOGENESIS (OCIF) (VARIANTS), CDNA, METHOD FOR PREPARING PROTEIN, METHOD FOR TREATMENT OF OSTEOPOROSIS, METHOD FOR TREATMENT AND/OR IMPROVEMENT OF BONE MASS RECOVERY, METHOD FOR TREATMENT OF INJURE ASSOCIATED WITH OSSEOUS METABOLISM, TRANSFORMED STRAIN ESCHERICHIA COLI PBK/01F10 AND PHARMACEUTICAL COMPOSITION 1996
  • Goto Masaaki
  • Tsuda Ehjsuke
  • Motizuki Siniti
  • Jano Kazuki
  • Kobajasi Fumie
  • Sima Nobujuki
  • Jasuda Khisataka
  • Nakagava Nobuaki
  • Morinaga Tomonori
  • Ueda Masatsugu
  • Khigasio Kandzi
RU2238948C2
GLAUCOMA TREATMENT 2018
  • Bruce Lars
  • Bruce Adam
RU2759998C2
NOVEL PROTEINS AND METHODS OF THEIR PREPARING 1996
  • Goto Masaaki
  • Tsuda Ehjsuke
  • Motizuki Siniti
  • Jano Kazuki
  • Kobajasi Fumie
  • Sima Nobujuki
  • Jasuda Khisataka
  • Nakagava Nobuaki
  • Morinaga Tomonori
  • Ueda Masatsugu
  • Khigasio Kandzi
RU2194714C2
Siglec-15 ANTIBODY 2010
  • Khiruma Josikharu
  • Tsuda Ejsuke
  • Takizava Takesi
  • Nakajama Makiko
RU2539790C2
ANTIBODY DIRECTED ON SIGLEC-15 PROTEIN, BOUND WITH OSTEOCLASTS 2008
  • Khiruma Josikharu
  • Tsuda Ejsuke
RU2475499C2
POLYMERIC MODIFYING AGENTS AND PHARMACEUTICAL COMPOSITIONS 2004
  • Kasuja Judzi
  • Khonma Masasi
RU2323227C2

RU 2 223 782 C2

Authors

Motizuki Siniti

Fudzise Nobuaki

Masujama Tikharu

Tsuda Eisuke

Khigasio Kandzi

Dates

2004-02-20Published

1999-10-28Filed